Company news

Lineage Cell Therapeutics, Inc. news in 2026

Lineage Cell Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Lineage Provides Update on ReSonance® Program for Hearing Loss

October 29, 2026

Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform

September 8, 2026

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

July 30, 2026

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

July 13, 2026

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

July 6, 2026

Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

May 5, 2026

OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026

May 4, 2026

Lineage Announces Formation of Scientific Advisory Board

April 13, 2026

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease

March 24, 2026

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 5, 2026

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026

February 26, 2026

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

January 6, 2026

Lineage Cell Therapeutics Issues Letter to Stockholders

January 5, 2026

Calls in 2026

Decks in 2026